HealthTech
Tempus
Tempus raises $200M Series F at $8.1B valuation
$200M
Total Raised
Series F
Latest Round
2015
Founded
1000+
Employees
Chicago, IL
1 min read
Quick Facts
Valuation
$8.1B
Latest Round Size
$200M
Latest Round Date
September 2020
Tempus: Series F Funding Round
Tempus has successfully raised $200M in Series F funding, reaching a valuation of $8.1B.
Company Overview
AI-powered precision medicine platform
Funding Details
The Series F round was led by Baillie Gifford, with participation from Franklin Templeton.
Company Information
- Headquarters: Chicago, IL
- Founded: 2015
- Employees: 1000+
- Category: HealthTech
Investment
Tempus plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Baillie Gifford: Verified investor in Series F
- Franklin Templeton: Verified investor in Series F
Key Investors
Baillie Gifford
Lead Investor
Verified investor in Series F
Franklin Templeton
Investor
Verified investor in Series F
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
HealthTech
Zingage
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
Editorial Team
Oct 9, 2025
1 min read•$12.5M
HealthTech
AccelerateStack Platform
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Michael Rodriguez
Oct 8, 2025
3 min read•$75M
HealthTech
Duos
Duos raises $130M Growth at $600M valuation
Duos raises $130M in Growth at $600M valuation. Digital health platform for Medicare beneficiaries...
Editorial Team
Oct 7, 2025
1 min read•$130M